AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KAUG 113 min read$ARI

Apollo Commercial Real Estate Finance, Inc. (ARI): Results of Operations and Financial Condition

Apollo Commercial Real Estate Finance, Inc. (ARI) filed an SEC Form 8-K — Results of Operations and Financial Condition. 8-K false 0001467760 0001467760 2026-08-10 2026-08-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10

Original reporting
SEC EDGAR 8-K
Published Aug 11, 2026, 12:56 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 10:33 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$ARI
Neutral
low confidence
Mentioned
$ARI
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ARINeutralMed
01

Why it matters

The filing itself is a new disclosure event for ARI, but the provided text does not include the underlying performance metrics needed to forecast direction.

02

Market read

Traders should treat this as an earnings-results release event for ARI and verify the attached exhibits for the actual numbers and any outlook changes.

03

What to watch

Traders should focus on Exhibit 99.1/99.2 for net interest income, credit performance, leverage/liquidity, and any outlook language, since those are the drivers of ARI’s valuation.

Relevance 7/10Novelty 6/10Timing: filed Aug 10, 2026 after quarter ended June 30, 2026 results were issued

Background

Apollo Commercial Real Estate Finance, Inc. (ARI) reported financial results for the quarter ended June 30, 2026 in an SEC 8-K, attaching a summary press release and a detailed presentation.

Company-level read

Ticker impact

$ARINeutralLow confidence
Context

ARI filed an 8-K with Item 2.02, furnishing its quarter ended June 30, 2026 financial results via press release and presentation.

Expected impact

Near-term volatility is possible once traders digest the attached Exhibit 99.1/99.2 details, but direction cannot be inferred from the provided text.

Evidence & confidence

The filing confirms results were issued on Aug 10, 2026, yet the article body contains no metrics (earnings, NII, credit losses, guidance) to assess upside or downside.

Market effects

Sector

Adds incremental datapoint for commercial real estate finance credit and earnings momentum, but no sector-wide conclusion is supported by the provided text.

Regional

No regional exposure details are provided in the scraped body.

Global

No global macro or cross-border funding impacts are disclosed in the provided text.

Counterpoint

What could challenge this read

Because the scraped body omits the actual financial figures, the market reaction may hinge on specific credit-quality or guidance items that are not visible here.

Key entities

  • public_company
    Apollo Commercial Real Estate Finance, Inc.

    Subject of the SEC 8-K, furnishing results for the quarter ended June 30, 2026 via Exhibits 99.1 and 99.2.

  • regulatory_filing
    SEC Form 8-K

    Current report used to furnish results of operations and financial condition.

Read at source← All news

Related articles

JUN 15
$ARIMedAI 8/10

Apollo Commercial Real Estate Finance, Inc. Declares Quarterly Common Stock Dividend and Provides Update on Review of Strategic Alternatives

Apollo Commercial Real Estate Finance (NYSE:ARI) said its board declared a $3.75 per-share quarterly common stock dividend, payable July 15, 2026 to holders of record June 30, 2026, with most classified as return of capital. After reviewing strategic alternatives, the board determined dissolution and liquidation are advisable, subject to stockholder approval, and ARI plans to file a preliminary SEC proxy statement.

manilatimes.net4 min
AUG 13
$LLYMedAI 8/10

Lilly Highlights Sleep Apnea Drug Progress and Sleep-Wake Disorder Acquisition in Q2 Report

Eli Lilly reported Q2 2026 results, saying worldwide revenue rose 48% to $23.0B, driven by volume growth led by Mounjaro and Zepbound, and raised full-year revenue guidance to $85B-$87B. In pipeline updates, the company said its triple agonist retatrutide improved obstructive sleep apnea in trials. Lilly also completed its acquisition of Centessa Pharmaceuticals to advance sleep-wake disorder treatments.

sleepreviewmag.com4 min
AUG 13
$QTIMedAI 8/10

QT Imaging (QTI) Q2 2026 Earnings Call Transcript

QT Imaging Holdings (QTI) reported Q2 2026 revenue of $7.4 million, up 103% year over year, driven by 15 scanner shipments. First-half revenue was $14 million. Fiscal 2026 guidance calls for about $39 million revenue. Q2 gross margin was 41%; operating loss $1.9 million and net loss $11.1 million. Company extended debt to 2029 and raised $10 million via an offering.

fool.com7 min
AUG 13
$FENCMed

Adherex Technologies Q2 Earnings Call Highlights

Fennec Pharmaceuticals (NASDAQ:FENC) reported Q2 results on an earnings call. Net product sales were $17.1 million, up 78% year over year. Non-GAAP adjusted EBITDA was $2.8 million versus a $1.2 million loss a year earlier. Cash and cash equivalents were $41.2 million at June 30, 2026. Management cited PEDMARK momentum and no quantitative 2026 revenue outlook.

yahoo.com6 min
AUG 13
$MIDDMedAI 8/10

Middleby Q2 Earnings Call Highlights

Middleby (NASDAQ:MIDD) said dealer-channel growth remains positive but should moderate in H2, with Q3 and Q4 growth driven mainly by chain customers. Q2 organic adjusted EBITDA margin was 25.8%, below expectations due to mix, inflation and ice and beverage investments. Q2 adjusted EBITDA was ~$193M and adjusted EPS $2.35. Full-year organic growth outlook raised to 6% to 8%.

yahoo.com6 min
AUG 13
$HROWMed

Harrow Q2 Earnings Call Highlights

Harrow (NASDAQ:HROW) reported Q2 revenue of $15.6M for IHEEZO, with demand up to 65,477 units (+44% sequential, +34% YoY) but revenue lagging due to distributor sell-through of prior inventory. Management cited normalized channel inventory, ~25% higher net pricing effective July 1, gross margin 71%, and cash of $83.9M. Harrow also discussed BYOOVIZ launch, VEVYE PBM coverage, and a pending TYRVAYA acquisition.

yahoo.com6 min